Companies
Companies
University of Delaware’s Groundbreaking Biomanufacturing Hub Boosts Economic Growth and Innovation
🏗️ The University of Delaware breaks ground on the SABRE Center, a biomanufacturing facility, to boost economic growth in biopharmaceuticals. 💼💰💡🌍🏭💪
Revolutionary Biomethane Reactor Sold to Danish CCU Specialist
📅 Electrochaea GmbH has sold a BioCat bioreactor to Danish CCU specialist Again AS. 👥 Again AS uses CO2-fixing archaea to manufacture carbon-negative chemicals at an industrial scale. 💰 Electrochaea sold the bioreactor to Again AS, enriching its R&D work. ♻️ Electrochaea sets a new industry standard for resource efficiency and adaptive bioreactor technology. ⚡️ Electrochaea's biotechnology produces CO2-neutral synthetic methane as a fossil-free alternative for LNG.
Breaking: Oncology Startup Flindr Raises €20m for Cancer Treatment Breakthrough
📢 Flindr Therapeutics BV secures €20m Series A financing! 💰 Funding to advance first-in-class RNF31 inhibitors for cancer treatment. 🩸🔬
Medicare to Increase Reimbursement for Cell & Gene Therapy in 2025
📰 CMS proposes increasing reimbursement for cell & gene therapies for Medicare, aligning Medicaid plans for sickle cell disease. 💰 🏥 Payments for gene therapy could increase to 75 of cost. 🩺 Aim is to provide practical reimbursement strategy. 💡
Nordic Bioproducts Group revolutionizes cellulose production cutting emissions by 72
1. 🌱 Nordic Bioproducts Group 🚀 opens its first production facility in Lappeenranta! ♻️ Expecting €40m revenue and 🌍📉 emissions reduction. 2. Nordic Bioproducts Group opens its first production facility in Lappeenranta, generating revenue and reducing emissions with innovative technology.
Swiss Biotech Breaks Records with Massive Growth!
📢 Swiss biotech industry breaks records with CHF7.3bn turnover in 2023! 💰 Capital investment soars to CHF2bn, fueled by collaboration and product approvals. 🌍 High exports and global participation at Swiss Biotech Day. Hope for the future! 🚀
Ipsen’s $18bn Pipeline Expansion Targets Movement Disorders
🔬 Ipsen SA and Skyhawk Therapeutics Inc join forces in a groundbreaking $1.8bn deal to treat rare neurological disorders. 💪🧠
AmphiStar BV Raises €6 Million to Boost Production and Create Jobs
🌟 AmphiStar BV secures €6m funding to expand production 📈, enhance R&D, and build a state-of-the-art facility 🏭. Hiring 15 new employees! 👥
Revolutionary Partnership for Cellular Immunotherapies!
📢 SCG Cell Therapy and A*STAR collaborate to develop scalable manufacturing processes for cellular immunotherapies. 💊🔬 High-quality products and talent development are prioritized. 🌍👥
AmphiStar BV Raises €6m to Revolutionize Biosurfactant Production
📢 Waste-based biosurfactants producer Amphistar BV secures €6m to expand production and build a state-of-the-art facility. 🌱🌳
